Cancer cells frequently exhibit dysfunctional regulation of HR, which may be linked to somatic or germ-line mutations in proteins that regulate RAD51, such as BRCA2, PALB2, BLM, p53 and others (19,35–37). Here, RAD51 is linked to cancer.